/R E P E A T -- Notice to the media - Government of Canada officials to hold a technical briefing on coronavirus disease in Canada/
OTTAWA, ON, July 30, 2021 /CNW/ - Government of Canada officials will hold a media technical briefing on data and modelling.
Officials will be available to answer questions from the media following their remarks.
Date July 30, 2021
Time 11:00 AM (EDT)
Location
The media technical briefing will be held virtually.
Media will be able to ask questions via teleconference.
Toll-free (Canada/US) dial-in number: 1-866-206-0153 Local dial-in number: 613-954-9003
Passcode: 1622050#
To obtain the briefing material under embargo, please RSVP by email at [email protected].
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024.
Highlights for the Quarter:
Net income available to common...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...